MedTrace Logo

TRC-PAD Program: In-Clinic Trial-Ready Cohort

NCT04004767 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2024-06-27

No results posted yet for this study

Summary

The purpose of the TRC-PAD study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention trials utilizing the APT Webstudy and subsequent referral to in-clinic evaluation and biomarker confirmation. Participants with known biomarker status may have direct referral to the Trial-Ready Cohort.

If you are interested in being selected for the TRC-PAD study, you should first enroll in the APT Webstudy (https://www.aptwebstudy.org/welcome).

Conditions

  • Preclinical Alzheimer's Disease
  • Prodromal Alzheimer's Disease
  • Alzheimer Disease
  • Dementia

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Alzheimer's Therapeutic Research Institute

    collaborator OTHER

  • Alzheimer's Clinical Trials Consortium

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • Cleveland Clinic Lou Ruvo Center for Brain Health

    collaborator UNKNOWN

  • University of Southern California

    lead OTHER

Principal Investigators

  • Paul Aisen, MD · USC Alzheimer's Therapeutic Research Institute (ATRI)

  • Reisa Sperling, MD · Brigham and Women's Hospital

  • Jeffrey Cummings, MD · Cleveland Clinic Lou Ruvo Center for Brain Health

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-04
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04004767 on ClinicalTrials.gov